Imaging scale meets a growing AI software engine
- RadNet operated 442 imaging centers at the end of Q2 2026, with 36% held in health system joint ventures.
- Advanced imaging reached 29.9% of Q2 2026 procedures, driven by MRI, CT, and PET/CT demand.
- Digital Health ARR reached $106 million at Q2 2026, up 97% year over year, with a target of $140 million by year-end.
- The new FDA-cleared breast ultrasound AI reduces radiologist interpretation time by 37%.
- The stock carries risk because labor costs, debt, integration hurdles, and weather disruptions can hit cash flow.
More scans, smarter schedule
The bull case is simple. More imaging is moving out of hospitals and into lower-cost outpatient centers. RadNet is one of the largest pure plays on that shift. It continues moving its mix toward higher-value advanced imaging, which made up 29.9% of Q2 2026 procedures. Proposed Medicare site neutrality rules could cut hospital non-contrast imaging fees by up to 50%, providing a massive catalyst for RadNet to form more joint ventures.
RadNet is not only adding centers, but trying to make each one handle more patients. TechLive, remote technologist tools, and AI scheduling help fill slots and reduce room downtime. Management targets processing 15% of total network volume through AI automated draft reporting by year-end 2026 and 50% by mid-2027, attacking the radiologist labor shortage directly.
Digital Health is the second leg of the thesis. Annual recurring revenue reached $106 million in Q2 2026, up 97% from the prior year. Recent FDA clearance for DeepHealth breast ultrasound adds another billed product to a portfolio that includes Gleamer, CIMAR, iCAD, and See-Mode.
The bear case remains focused on execution. The core imaging business needs scarce technologists and radiologists, driving wage inflation. Digital Health is growing fast, but it still requires integration work to prove it can become highly profitable. An open question is how fast commercial payers will adopt and reimburse the new breast ultrasound AI in the second half of 2026.
Paid per scan, then per workflow
RadNet makes most of its money by running freestanding imaging centers. Doctors send patients for MRI, CT, PET/CT, mammography, ultrasound, X-ray, and other scans. RadNet gets paid by commercial insurers, Medicare, Medicaid, patients, and capitated health plans. Capitation means RadNet gets a fixed amount per member to make imaging available.
The center model works best when rooms stay full, staff is available, and the scan mix moves toward advanced imaging. Advanced scans bring higher revenue, but they also require higher-cost supplies like PET tracers. Proposed 2027 Medicare cuts to hospital non-contrast imaging make RadNet's lower-cost model more attractive for partnerships.
Health system joint ventures are a key growth tool. RadNet manages many centers with hospital or health system partners, which helps it get referrals and enter new markets. As of Q2 2026, 157 of 442 centers, or 36%, were held in health system partnerships.
Digital Health sells cloud workflow software, image management, AI reading tools, and related services to RadNet and outside customers. External sales now make up 63% of the ARR base. The goal is to turn radiology software into a higher-margin, recurring revenue business, directly monetizing tools like automated breast ultrasound reporting.
What RadNet sells
Outpatient imaging centers
This is the main business. Centers perform MRI, CT, PET/CT, mammography, ultrasound, X-ray, and other exams for patients sent by doctors.
Advanced imaging
MRI, CT, PET/CT, PSMA, and amyloid scans are pushing the mix higher. Advanced imaging reached 29.9% of Q2 2026 procedure volume.
DeepHealth OS and workflow software
DeepHealth OS connects imaging data, workflow, and reporting. Digital Health served more than 2,890 customers early in 2026, including RadNet and outside users.
TechLive and AlphaRT
TechLive supports remote scanning work, while AlphaRT adds remote technologist staffing and MRI safety alerts. These tools target one of RadNet's biggest limits, which is not enough skilled staff.
Clinical AI tools
EBCD for breast screening, plus lung, prostate, and ultrasound AI, aim to improve detection and speed. Newly FDA-cleared DeepHealth breast ultrasound automates lesion detection and BI-RADS categorization.
Acquired AI assets
Acquisitions like Gleamer, CIMAR, iCAD, and SmartMammo add AI breast health, cloud image storage, PACS, and automated draft reporting. They expand the software platform but also raise integration risk.
Two businesses, one still dominant
Segment mix uses Q1 2026 operating revenue before intersegment eliminations: Imaging Center revenue of $556.8 million and Digital Health revenue of $29.1 million. Digital Health ARR reached $106 million in Q2 2026, making it the key growth metric.
What can break
Labor stays tight
High impact · High oddsRadNet needs technologists to run scanners and radiologists to read images. Management expects a headwind in labor costs. They are targeting 50% of volume on AI autodraft by mid-2027 to offset wage pressure, but execution is key.
Digital Health integration slips
Medium impact · Medium oddsDigital Health is growing fast through acquisitions. Q2 2026 ARR was $106 million. The payoff depends on integrating iCAD, See-Mode, CIMAR, and Gleamer into one useful platform while driving operating margins higher.
Weather and seasonality hit visits
Medium impact · Medium oddsRadNet's first quarter is often weaker because of winter weather and patient deductibles resetting. Severe weather events reduce revenue and adjusted EBITDA. Lost appointments are hard to fully recover.
Debt limits room for error
High impact · Medium oddsRadNet is using acquisitions and equipment spending to grow. If growth slows or integration costs rise, the balance sheet could become a bigger concern for equity holders.
Reimbursement changes create volatility
Medium impact · Low oddsMedicare rate cuts have been a long-running worry for imaging companies. The 2027 Medicare fee schedule screens net neutral, but future rules can always change scan economics. Proposed site neutrality rules could actually push more volume from hospitals to RadNet.
In one breath
What does RadNet do?
RadNet runs outpatient imaging centers where patients get scans like MRI, CT, PET/CT, mammography, ultrasound, and X-ray. It also sells radiology AI and workflow software through its Digital Health segment.
Why does advanced imaging matter for RadNet?
Advanced imaging can bring higher revenue per exam than routine scans. In Q2 2026, advanced imaging was 29.9% of procedures, helped by demand in MRI, CT, and PET/CT.
Is RadNet an AI company or an imaging center company?
Today it is still mostly an imaging center company by revenue. Digital Health is much smaller, but ARR reached $106 million in Q2 2026 and is the part investors watch for software-like growth.
What is the main risk for RadNet stock?
The main risk is execution. RadNet must handle labor shortages, debt, acquisition integration, and weather disruption while proving that AI tools raise throughput and Digital Health becomes more profitable.
